Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis: a 1994 interim report

W C Maddrey1

  • 1University of Texas Southwestern Medical Center at Dallas.

Gastroenterology Clinics of North America
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe hepatitis from methyldopa.

Gastroenterology·2012
Same author

Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine.

Hepatology (Baltimore, Md.)·2001
Same author

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Journal of medical virology·2001
Same author

A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine.

Vaccine·2001
Same author

The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.

American journal of therapeutics·2001
Same author

Alcohol-induced liver disease.

Clinics in liver disease·2001

Accurate diagnostic tests and vaccines for hepatitis viruses A through E have advanced significantly. Research is ongoing for new treatments for chronic hepatitis B and C, with interferon currently being the primary option.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Viral infections are a major cause of acute and chronic liver diseases.
  • Significant advancements in diagnostics and vaccines for hepatitis viruses A-E have been made.
  • Understanding the pathogenesis of chronic hepatitis B and C is crucial for developing effective treatments.

Purpose of the Study:

  • To review the current state of diagnostics and vaccines for hepatitis viruses.
  • To discuss the pathogenesis of chronic hepatitis B and C.
  • To explore promising therapeutic approaches for chronic viral hepatitis.

Main Methods:

  • Review of scientific literature on hepatitis viruses.
  • Analysis of diagnostic test availability and efficacy.

Related Experiment Videos

  • Evaluation of vaccine development and impact.
  • Assessment of current and emerging therapeutic strategies.

    • Main Results:

    • Readily available diagnostic tests for hepatitis viruses A through E exist.
    • Effective vaccines are available for hepatitis A and B.
    • Interferon is a proven treatment for some patients with chronic hepatitis B and C.
    • Newer antiviral agents are under development for combination therapy.

    Conclusions:

    • Viral hepatitis remains a significant global health concern.
    • Continued research is essential for developing novel treatments and preventative strategies.
    • Combination therapies hold promise for improving outcomes in chronic hepatitis B and C.